Merit Medical Systems (MMSI)
(Delayed Data from NSDQ)
$74.03 USD
-0.15 (-0.20%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $74.03 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Price, Consensus and EPS Surprise
MMSI 74.03 -0.15(-0.20%)
Will MMSI be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MMSI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MMSI
Merit Medical (MMSI) Earnings Expected to Grow: Should You Buy?
BDX or MMSI: Which Is the Better Value Stock Right Now?
MMSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
BDX vs. MMSI: Which Stock Is the Better Value Option?
Merit Medical (MMSI) Down 0.6% Since Last Earnings Report: Can It Rebound?
Other News for MMSI
Piper Sandler Keeps Their Buy Rating on Merit Medical Systems (MMSI)
Outperform Rating Maintained for Merit Medical Systems Amid Strong Growth and Profitability Projections
Decoding 7 Analyst Evaluations For Merit Medical Systems
Merit Medical initiated with bullish view at CL King
Merit Medical Systems (MMSI) Poised for Growth: Buy Rating Affirmed on Strategic Initiatives and New Product Launch